{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:35:07Z","timestamp":1777952107322,"version":"3.51.4"},"reference-count":18,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Interstitial lung diseases (ILDs) represent a heterogenous group of disorders affecting the lung parenchyma. Patients with ILD are frequently admitted to hospital secondary to respiratory decompensation which can result in acute respiratory failure (ARF). High flow nasal oxygen (HFNO) has increasingly been used in other causes of ARF following the recommendations of the European Respiratory Society. A review was undertaken to evaluate the question: in adults with ILD and ARF without hypercapnia, is HFNO better than conventional oxygen therapy (COT) at reducing symptoms and all-cause mortality outcomes? Medline via PubMed, EMBASE via OVID and the Cochrane Library were searched between 1975 and 20 June 2025. 2362 papers were identified with 17 undergoing full-text review. Two systematic reviews met inclusion criteria and directly answered the three-part question. Study information, participant demographics, key results and study weaknesses were established for each paper. Neither systematic review found HFNO improved mortality outcomes, when compared with COT, to a statistically significant threshold for patients with ILD with ARF. Reported median survival with HFNO use was 21.0 days (95% CI 13.0 to 61.0) and COT use 133 days (95% CI 26.0 to 374.0, p=0.1323). Inpatient mortality with HFNO use ranged between 26.5% and 59.1%. Symptomatically, one review reported a numerical improvement in the Quality of Death and Dying Score for the HFNO group versus the COT group (4.58 \u00b1 0.67 vs 4.09 \u00b1 0.96). There is limited evidence to suggest that HFNO improves mortality outcomes for patients with ILD in ARF. However, it may be beneficial for symptom management. Mortality remains high despite HFNO use, thus careful discussions with patients and their relatives are required should a trial be used in the setting of ARF.<\/jats:p>","DOI":"10.1136\/emermed-2025-215112","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:30:14Z","timestamp":1763739014000},"page":"833-835","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Adults with interstitial lung disease and acute respiratory failure without hypercapnia: when should high flow nasal oxygen be used?"],"prefix":"10.1136","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1991-3897","authenticated-orcid":false,"given":"Laura","family":"White","sequence":"first","affiliation":[{"name":"Lancaster Medical School, Lancaster University, Lancaster, England, UK"},{"name":"Respiratory Department, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ellam","sequence":"additional","affiliation":[{"name":"Lancaster Medical School, Lancaster University, Lancaster, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Hickman","sequence":"additional","affiliation":[{"name":"Lancaster Medical School, Lancaster University, Lancaster, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2026050404400571000_42.12.833.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2026050404400571000_42.12.833.2","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00009113"},{"key":"2026050404400571000_42.12.833.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297832","article-title":"A scoping review of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis (IPF)","volume":"19","author":"Bramhill","year":"2024","journal-title":"PLoS One"},{"key":"2026050404400571000_42.12.833.4","doi-asserted-by":"crossref","unstructured":"W\u00e4lscher J , Witt S , Schwarzkopf L , et al . Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment \u2013 a German claims data analysis. Respir Res 2020;21. doi:10.1186\/s12931-020-01335-x","DOI":"10.1186\/s12931-020-01335-x"},{"key":"2026050404400571000_42.12.833.5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.7150\/ijms.32752","article-title":"Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights","volume":"16","author":"Faverio","year":"2019","journal-title":"Int J Med Sci"},{"key":"2026050404400571000_42.12.833.6","doi-asserted-by":"crossref","unstructured":"Leuschner G , Behr J . Acute Exacerbation in Interstitial Lung Disease. Front Med 2017;4. doi:10.3389\/fmed.2017.00176","DOI":"10.3389\/fmed.2017.00176"},{"key":"2026050404400571000_42.12.833.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.01.006"},{"key":"2026050404400571000_42.12.833.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-463PP"},{"key":"2026050404400571000_42.12.833.9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01574-2021","article-title":"ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure","volume":"59","author":"Oczkowski","year":"2022","journal-title":"Eur Respir J"},{"key":"2026050404400571000_42.12.833.10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102956","article-title":"High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis","volume":"13","author":"Pagliaro","year":"2024","journal-title":"J Clin Med"},{"key":"2026050404400571000_42.12.833.11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.29390\/001c.89284","article-title":"Effect of noninvasive respiratory support on interstitial lung disease with acute respiratory failure: A systematic review and meta-analysis","volume":"59","author":"Sanguanwong","year":"2023","journal-title":"Can J Respir Ther"},{"key":"2026050404400571000_42.12.833.12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.annemergmed.2019.09.009","article-title":"High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Relieving Dyspnea in Emergency Palliative Patients With Do-Not-Intubate Status: A Randomized Crossover Study","volume":"75","author":"Ruangsomboon","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2026050404400571000_42.12.833.13","article-title":"High-flow Nasal Cannula: Mechanisms of Action and Adult and Pediatric Indications","volume":"10","author":"Lodeserto","year":"2018","journal-title":"Cureus"},{"key":"2026050404400571000_42.12.833.14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s43678-024-00695-3","article-title":"Just the facts: approach to the patient with Interstitial Lung Disease (ILD) in the emergency department","volume":"26","author":"Lipinski","year":"2024","journal-title":"Can J Emerg Med"},{"key":"2026050404400571000_42.12.833.15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000489890","article-title":"Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study","volume":"96","author":"Koyauchi","year":"2018","journal-title":"Respiration"},{"key":"2026050404400571000_42.12.833.16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/ejcdt.ejcdt_33_18","article-title":"High-flow nasal oxygen therapy versus noninvasive ventilation in chronic interstitial lung disease patients with acute respiratory failure","volume":"67","author":"Shebl","year":"2018","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2026050404400571000_42.12.833.17","first-page":"301","article-title":"High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study","volume":"82","author":"Omote","year":"2020","journal-title":"Nagoya J Med Sci"},{"key":"2026050404400571000_42.12.833.18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/CPM.0000000000000312","article-title":"Noninvasive Oxygenation Strategies For Acute Exacerbation of Interstitial Lung Disease: A Retrospective Single-center Study and a Review of the Literature","volume":"26","author":"Imai","year":"2019","journal-title":"Clin Pulm Med"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2025-215112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:40:20Z","timestamp":1777894820000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2025-215112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":18,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,11,21]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/emermed-2025-215112"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2025-215112","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}